|
gptkbp:instanceOf
|
gptkb:drug
gptkb:Corticosteroid
|
|
gptkbp:activeIngredient
|
gptkb:methandrostenolone
gptkb:nandrolone
gptkb:oxandrolone
gptkb:stanozolol
testosterone
|
|
gptkbp:administeredBy
|
injection
oral
topical
|
|
gptkbp:affects
|
protein synthesis
bone density
nitrogen retention
red blood cell production
|
|
gptkbp:cause
|
addiction
psychological dependence
stunted growth in adolescents
virilization in women
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:detects
|
blood test
urine test
|
|
gptkbp:discoveredIn
|
1930s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
anabolic steroids
|
|
gptkbp:isAbusedBy
|
athletes
bodybuilders
|
|
gptkbp:isBannedBy
|
gptkb:International_Olympic_Committee
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:isIllegalWithoutPrescriptionIn
|
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:isTestedForIn
|
sports competitions
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:relatedTo
|
corticosteroids
androgenic steroids
|
|
gptkbp:sideEffect
|
gptkb:cardiovascular_disease
mood swings
hypertension
hair loss
infertility
aggression
acne
liver damage
gynecomastia
testicular atrophy
|
|
gptkbp:usedFor
|
performance enhancement
muscle growth
treating hormone deficiencies
|
|
gptkbp:bfsParent
|
gptkb:UK_drug_classification_system
|
|
gptkbp:bfsLayer
|
6
|